Article
Preclinical evaluation of the efficacy of α-Difluoromethylornithine and Sulindac against…
medRxiv · 2025 · Ignatenko, N. A.; Trinh, H.; Wagner, A. M.; Gerner, E. W.; Bime, C.; Hsu, C.-H.; Besselsen, D. G.
Key facts
| Title | Preclinical evaluation of the efficacy of α-Difluoromethylornithine and Sulindac against SARS-CoV-2 infection |
|---|---|
| First author | Ignatenko, N. A.; Trinh, H.; Wagner, A. M.; Gerner, E. W.; Bime, C.; Hsu, C.-H.; Besselsen, D. G. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.02.26.640194 |
| Devices mentioned | BK110039, K123955 |
| Product codes mentioned | KIP, KIT, MVU, NDS, NJT, OHQ, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1